| Period | Period Low | Period High | Performance | |
|---|---|---|---|---|
| 1-Month | 10.95 +9.54% on 02/23/23 |
Period Open: 11.98
| 12.02 -0.12% on 03/09/23 | +0.02 (+0.17%) since 02/09/23 |
| 3-Month | 10.95 +9.54% on 02/23/23 |
Period Open: 11.88
| 12.02 -0.12% on 03/09/23 | +0.12 (+1.01%) since 12/09/22 |
| 52-Week | 3.26 +268.10% on 06/29/22 |
Period Open: 7.00
| 12.02 -0.12% on 03/09/23 | +5.00 (+71.43%) since 03/09/22 |
These two high-yield energy stocks double as top value plays.
Vivint Smart Home, Inc. (NYSE: VVNT), a leading smart home company in North America, celebrated Black History Month and kicked off Women’s History Month with a series of events focused on recognizing,...
Vivint Smart Home, Inc. (NYSE: VVNT), a leading smart home company in North America, was awarded a DEVIES Award in the Services Systems Integration category for its Spotlight Pro . DEVIES Awards...
Vivint Smart Home, Inc. (NYSE: VVNT), a leading smart home company in North America, was selected as “Home Security Company of the Year” in the seventh annual IoT Breakthrough Awards program. The...
Summit Partners, a leading alternative investment firm, today announced the promotion of 14 professionals across the firm’s global offices. Scott Ferguson, Paul Furer, Mark Nordstrom, Dayton Ogden and...
Vivint Smart Home, Inc. (NYSE: VVNT), a leading smart home company, in partnership with Vivint Gives Back, announced that together the company and organization concluded another incredibly successful year...
NRG Energy surprised investors with the announcement that it will acquire Vivint Smart Home.
This utility went shopping, and shareholders aren't happy with the purchase.
/PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Vivint Smart Home, Inc....
Vivint Smart Home, Inc. (NYSE: VVNT), a leading smart home company, in partnership with Vivint Gives Back, is celebrating the season of giving as Vivint Gives Back kicks off its annual Sub for Santa program....
/PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics...
/PRNewswire/ -- CASI Pharmaceuticals, Inc. (NASDAQ: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics...
/PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics...
/PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics...
/PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics...
/PRNewswire/ -- CASI Pharmaceuticals, Inc. (NASDAQ: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics...
LUND, SE / ACCESSWIRE / December 10, 2021 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV) , a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory...
Morning Markets Dec S&P 500 futures this morning are up by +0.21%. Stocks are seeing support from a rally in Chinese stocks today on signs that China’s central bank may soon ease monetary policy. In...
/PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics...
Palm Beach, FL – August 24, 2021 – FinancialNewsMedia.com News Commentary – Recently, approximately 1.2 million new liver cancer cases have been reporting around the world. The increasing intense...
/PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics...
/PRNewswire/ -- CASI Pharmaceuticals, Inc. (NASDAQ: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics...
/PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics...
/PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics...
/PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics...
/PRNewswire/ -- CASI Pharmaceuticals, Inc. (NASDAQ: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics...
LUND, SE / ACCESSWIRE / December 10, 2021 / BioInvent International AB ("BioInvent") (Nasdaq Stockholm:BINV) , a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory...
Morning Markets Dec S&P 500 futures this morning are up by +0.21%. Stocks are seeing support from a rally in Chinese stocks today on signs that China’s central bank may soon ease monetary policy. In...
/PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics...
Palm Beach, FL – August 24, 2021 – FinancialNewsMedia.com News Commentary – Recently, approximately 1.2 million new liver cancer cases have been reporting around the world. The increasing intense...
| 3rd Resistance Point | 12.04 |
| 2nd Resistance Point | 12.03 |
| 1st Resistance Point | 12.01 |
| Last Price | 12.00 |
| 1st Support Level | 11.99 |
| 2nd Support Level | 11.98 |
| 3rd Support Level | 11.96 |
| 52-Week High | 12.02 |
| Last Price | 12.00 |
| Fibonacci 61.8% | 8.67 |
| Fibonacci 50% | 7.64 |
| Fibonacci 38.2% | 6.60 |
| 52-Week Low | 3.26 |
